Breast cancer brain metastases are an increasing clinical problem. Studies have shown that brain metastases from breast cancer have a distinct genomic landscape to that of the primary tumour, including the presence of mutations that are absent in the primary breast tumour.
The genomic landscape of breast cancer brain metastases: a systematic review
. 2021 Jan;22(1):e7-e17. doi: 10.1016/S1470-2045(20)30556-8.
Alexander J Morgan 1, Athina Giannoudis 1, Carlo Palmieri 2Affiliations expand
- PMID: 33387511
- DOI: 10.1016/S1470-2045(20)30556-8
Abstract
Breast cancer brain metastases are an increasing clinical problem. Studies have shown that brain metastases from breast cancer have a distinct genomic landscape to that of the primary tumour, including the presence of mutations that are absent in the primary breast tumour. In this Review, we aim to review and evaluate genomic sequencing data for breast cancer brain metastases by searching PubMed, Embase, and Scopus for relevant articles published in English between database inception and May 30, 2020. Extracted information includes data for mutations, receptor status (eg, immunohistochemistry and Prediction Analysis of Microarray 50 [PAM50]), and copy number alterations from published manuscripts and supplementary materials. Of the 431 articles returned by the database search, 13 (3%) breast cancer brain metastases sequencing studies, comprising 164 patients with sequenced brain metastases, met all our inclusion criteria. We identified 268 mutated genes that were present in two or more breast cancer brain metastases samples. Of these 268 genes, 22 (8%) were mutated in five or more patients and pathway enrichment analysis showed their involvement in breast cancer-related signalling pathways, regulation of gene transcription, cell cycle, and DNA repair. Actionability analysis using the Drug Gene Interaction Database revealed that 15 (68%) of these 22 genes are actionable drug targets. In addition, immunohistochemistry and PAM50 data showed receptor discordancy between primary breast cancers and their paired brain metastases. This systematic review provides a detailed overview of the most commonly mutated genes identified in samples of breast cancer brain metastases and their clinical relevance. These data highlight the differences between primary breast cancers and brain metastases and the importance of acquiring and analysing brain metastasis samples for further study.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
- Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.Saunus JM, Quinn MC, Patch AM, Pearson JV, Bailey PJ, Nones K, McCart Reed AE, Miller D, Wilson PJ, Al-Ejeh F, Mariasegaram M, Lau Q, Withers T, Jeffree RL, Reid LE, Da Silva L, Matsika A, Niland CM, Cummings MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wani S, Anderson MJ, Fink JL, Holmes O, Kazakoff S, Leonard C, Newell F, Taylor D, Waddell N, Wood S, Xu Q, Kassahn KS, Narayanan V, Taib NA, Teo SH, Chow YP, kConFab, Jat PS, Brandner S, Flanagan AM, Khanna KK, Chenevix-Trench G, Grimmond SM, Simpson PT, Waddell N, Lakhani SR.J Pathol. 2015 Nov;237(3):363-78. doi: 10.1002/path.4583. Epub 2015 Aug 19.PMID: 26172396
- Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.Priedigkeit N, Hartmaier RJ, Chen Y, Vareslija D, Basudan A, Watters RJ, Thomas R, Leone JP, Lucas PC, Bhargava R, Hamilton RL, Chmielecki J, Puhalla SL, Davidson NE, Oesterreich S, Brufsky AM, Young L, Lee AV.JAMA Oncol. 2017 May 1;3(5):666-671. doi: 10.1001/jamaoncol.2016.5630.PMID: 27926948 Free PMC article.
- Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.Hohensee I, Lamszus K, Riethdorf S, Meyer-Staeckling S, Glatzel M, Matschke J, Witzel I, Westphal M, Brandt B, Müller V, Pantel K, Wikman H.Am J Pathol. 2013 Jul;183(1):83-95. doi: 10.1016/j.ajpath.2013.03.023. Epub 2013 May 9.PMID: 23665199
- Genomic profiling of brain metastases: current knowledge and new frontiers.Neagu MR, Gill CM, Batchelor TT, Brastianos PK.Chin Clin Oncol. 2015 Jun;4(2):22. doi: 10.3978/j.issn.2304-3865.2015.06.04.PMID: 26112808 Review.
- Systemic therapies for melanoma brain metastases: which drug for whom and when?Ramanujam S, Schadendorf D, Long GV.Chin Clin Oncol. 2015 Jun;4(2):25. doi: 10.3978/j.issn.2304-3865.2015.06.06.PMID: 26112811 Review.
Cited by 9 articles
- Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors.Thulin A, Andersson C, Werner Rönnerman E, De Lara S, Chamalidou C, Schoenfeld A, Kovács A, Fagman H, Enlund F, Linderholm BK.Sci Rep. 2021 Dec 7;11(1):23548. doi: 10.1038/s41598-021-02903-x.PMID: 34876602 Free PMC article.
- Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer.Li L, Bai Y, Gao Y, Li D, Chen L, Zhou C, Feng M, Chen X, Jin W, Cao Y.Dis Markers. 2021 Nov 8;2021:7711151. doi: 10.1155/2021/7711151. eCollection 2021.PMID: 34790279 Free PMC article.
- Dissecting the Role of N6-Methylandenosine-Related Long Non-coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer.Zhang J, Shan B, Lin L, Dong J, Sun Q, Zhou Q, Chen J, Han X.Front Cell Dev Biol. 2021 Oct 6;9:711859. doi: 10.3389/fcell.2021.711859. eCollection 2021.PMID: 34692676 Free PMC article.
- Evolution of the Tumor Microenvironment toward Immune-Suppressive Seclusion during Brain Metastasis of Breast Cancer: Implications for Targeted Therapy.Noh MG, Kim SS, Kim YJ, Jung TY, Jung S, Rhee JH, Lee JH, Lee JS, Cho JH, Moon KS, Park H, Lee KH.Cancers (Basel). 2021 Sep 29;13(19):4895. doi: 10.3390/cancers13194895.PMID: 34638378 Free PMC article.
- Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival.Giannoudis A, Sartori A, Eastoe L, Zakaria R, Charlton C, Hickson N, Platt-Higgins A, Rudland PS, Irwin D, Jenkinson MD, Palmieri C.Breast Cancer Res Treat. 2021 Nov;190(2):241-253. doi: 10.1007/s10549-021-06364-8. Epub 2021 Sep 9.PMID: 34499316 Free PMC article.
Editor do blog: Julio Pereira – Neurocirugião – São Paulo CRM/SP 163.113 Site para Consulta: https://www.julio-pereira.com/ Consultório: (11)99503-8838 (WhatsApp) / (11)4200-2300 Atuando no Hospital Sírio-Libanês e na BP – A Beneficência Portuguesa de São Paulo.
CONFIRA NOSSOS SITES:
Cirurgia de Coluna
Tumor Cerebral
Aneurisma Cerebral
Radiocirurgia
Neuro Cancer
WeNeuro
